Emerging pathways driving early synaptic pathology in Alzheimer's disease

Biochemical and Biophysical Research Communications

Volumn 483, Issue 4, 2017, Pages 988-997

  Briggs, Clark A ^a   Chakroborty, Shreaya ^a   Stutzmann, Grace E ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Alzheimer's disease; Ca2+; Endoplasmic reticulum; IP3R; Lysosome; RyR; SOCE; Synaptic plasticity

Indexed keywords

STROMAL INTERACTION MOLECULE 2; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ALZHEIMER DISEASE; AMNESIA; CALCIUM CELL LEVEL; CALCIUM SIGNALING; ENDOPLASMIC RETICULUM; HUMAN; INTRACELLULAR SIGNALING; LYSOSOME; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; REVIEW; SYNAPSE; TRANSCRIPTOMICS; ANIMAL; COGNITIVE DEFECT; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; CALCIUM SIGNALING; COGNITION DISORDERS; HUMANS; NEURONAL PLASTICITY; SYNAPSES;

EID: 84992708501     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.09.088     Document Type: Review

References (171)

1. [1] Allen, D., Bond, C.T., Lujan, R., Ballesteros-Merino, C., Lin, M.T., Wang, K., Klett, N., Watanabe, M., Shigemoto, R., Stackman, R.W. Jr., Maylie, J., Adelman, J.P., The SK2-long isoform directs synaptic localization and function of SK2-containing channels. Nat. Neurosci. 14 (2011), 744–749.
2. [2] Antonell, A., Llado, A., Altirriba, J., Botta-Orfila, T., Balasa, M., Fernandez, M., Ferrer, I., Sanchez-Valle, R., Molinuevo, J.L., A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease. Neurobiol. Aging 34 (2013), 1772–1778.
3. [3] Area-Gomez, E., Schon, E.A., Mitochondria-associated ER membranes and Alzheimer disease. Curr. Opin. Genet. Dev. 38 (2016), 90–96.
4. [4] Arnold, S.E., Louneva, N., Cao, K., Wang, L.S., Han, L.Y., Wolk, D.A., Negash, S., Leurgans, S.E., Schneider, J.A., Buchman, A.S., Wilson, R.S., Bennett, D.A., Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol. Aging 34 (2013), 157–168.
5. [5] Bandara, S., Malmersjo, S., Meyer, T., Regulators of calcium homeostasis identified by inference of kinetic model parameters from live single cells perturbed by siRNA. Sci. Signal, 6, 2013, ra56.
6. [6] Barucker, C., Sommer, A., Beckmann, G., Eravci, M., Harmeier, A., Schipke, C.G., Brockschnieder, D., Dyrks, T., Althoff, V., Fraser, P.E., Hazrati, L.N., George-Hyslop, P.S., Breitner, J.C., Peters, O., Multhaup, G., Alzheimer amyloid peptide abeta42 regulates gene expression of transcription and growth factors. J. Alzheimer's Dis. 44 (2015), 613–624.
7. [7] Bellinger, A.M., Reiken, S., Dura, M., Murphy, P.W., Deng, S.X., Landry, D.W., Nieman, D., Lehnart, S.E., Samaru, M., Lacampagne, A., Marks, A.R., Remodeling of ryanodine receptor complex causes “leaky” channels: a molecular mechanism for decreased exercise capacity. Proc. Natl. Acad. Sci. (USA) 105 (2008), 2198–2202.
8. [8] Berridge, M.J., The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32 (2002), 235–249.
9. [9] Berridge, M.J., Calcium hypothesis of Alzheimer's disease. Pflugers Arch. 459 (2010), 441–449.
10. [10] Berridge, M.J., Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 7 (2013), 2–13.
11. [11] Bers, D.M., Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring. Circ. Res. 110 (2012), 796–799.
12. [12] Bezprozvanny, I., Supnet, C., Sun, S., Zhang, H., De Strooper, B., Response to Shilling et al. J. Biol. Chem., 287, 2012, 20469, 10.1074/jbc.M111.300491.
13. [13] Blanz, J., Saftig, P., Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance. J. Neurochem, 2016, 10.1111/jnc.13517.
14. [14] Bradley, S.A., Steinert, J.R., Nitric oxide-mediated posttranslational modifications: impacts at the synapse. Oxid. Med. Cell Longev., 2016, 2016, 5681036.
15. [15] Brager, D.H., Cai, X., Thompson, S.M., Activity-dependent activation of presynaptic protein kinase C mediates post-tetanic potentiation. Nat. Neurosci. 6 (2003), 551–552.
16. [16] Briggs, C.A., Schneider, C., Richardson, J.C., Stutzmann, G.E., Beta amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice. Neurobiol. Aging 34 (2013), 1632–1643.
17. [17] Brini, M., Cali, T., Ottolini, D., Carafoli, E., Neuronal calcium signaling: function and dysfunction. Cell. Mol. Life Sci. 71 (2014), 2787–2814.
18. [18] Cai, Q., Tammineni, P., Alterations in mitochondrial quality control in Alzheimer's disease. Front. Cell. Neurosci., 10, 2016, 24.
19. [19] Cajigas, I.J., Tushev, G., Will, T.J., tom, D.S., Fuerst, N., Schuman, E.M., The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging. Neuron 74 (2012), 453–466.
20. [20] Castellani, R.J., Smith, M.A., Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’. J. Pathol. 224 (2011), 147–152.
21. [21] Castello, M.A., Jeppson, J.D., Soriano, S., Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease. BMC Neurol., 14, 2014, 169.
22. [22] Chakroborty, S., Briggs, C., Miller, M.B., Goussakov, I., Schneider, C., Kim, J., Wicks, J., Richardson, J.C., Conklin, V., Cameransi, B.G., Stutzmann, G.E., Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease. PLoS One, 7, 2012, e52056.
23. [23] Chakroborty, S., Kim, J., Schneider, C., West, A.R., Stutzmann, G.E., Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice. J. Neurosci. 35 (2015), 6893–6902.
24. [24] Chakroborty, S., Stutzmann, G.E., Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction. Sci. China Life Sci. 54 (2011), 752–762.
25. [25] Chakroborty, S., Stutzmann, G.E., Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures. Eur. J. Pharmacol. 739 (2014), 83–95.
26. [26] Chakroborty, S., Goussakov, I., Miller, M.B., Stutzmann, G.E., Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J. Neurosci. 29 (2009), 9458–9470.
27. [27] Chakroborty, S., Kim, J., Schneider, C., Jacobson, C., Molgó, J., Stutzmann, G.E., Early pre- and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. J. Neurosci. 32 (2012), 8341–8353.
28. 3 receptor channel gating. Neuron 58 (2008), 871–883.
29. [29] Choi, S., Maleth, J., Jha, A., Lee, K.P., Kim, M.S., So, I., Ahuja, M., Muallem, S., The TRPCs-STIM1-Orai interaction. Handb. Exp. Pharmacol. 223 (2014), 1035–1054.
30. [30] Clark, J.K., Furgerson, M., Crystal, J.D., Fechheimer, M., Furukawa, R., Wagner, J.J., Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice. Neurobiol. Learn. Mem. 125 (2015), 152–162.
31. [31] Coen, K., Flannagan, R.S., Baron, S., Carraro-Lacroix, L.R., Wang, D., Vermeire, W., Michiels, C., Munck, S., Baert, V., Sugita, S., Wuytack, F., Hiesinger, P.R., Grinstein, S., Annaert, W., Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 198 (2012), 23–35.
32. [32] Colacurcio, D.J., Nixon, R.A., Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res. Rev., 2016, 10.1016/j.arr.2016.05.004.
33. [33] Colton, C.A., Vitek, M.P., Wink, D.A., Xu, Q., Cantillana, V., Previti, M.L., Van Nostrand, W.E., Weinberg, J.B., Dawson, H., NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. (USA) 103 (2006), 12867–12872.
34. [34] Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993), 921–923.
35. [35] De Strooper, B., Karran, E., The cellular phase of Alzheimer's disease. Cell 164 (2016), 603–615.
36. [36] Dekosky, S.T., Scheff, S.W., Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27 (1990), 457–464.
37. [37] del Prete, D., Checler, F., Chami, M., Ryanodine receptors: physiological function and deregulation in Alzheimer disease. Mol. Neurodegener. 9 (2014), 21–29.
38. [38] Demuro, A., Parker, I., Cytotoxicity of intracellular abeta42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate. J. Neurosci. 33 (2013), 3824–3833.
39. [39] Disterhoft, J.F., Oh, M.M., Learning, aging and intrinsic neuronal plasticity. Trends Neurosci. 29 (2006), 587–599.
40. [40] Duggan, S.P., McCarthy, J.V., Beyond gamma-secretase activity: the multifunctional nature of presenilins in cell signalling pathways. Cell Signal 28 (2016), 1–11.
41. [41] Edmonds, E.C., Delano-Wood, L., Galasko, D.R., Salmon, D.P., Bondi, M.W., Subtle cognitive decline and biomarker staging in preclinical Alzheimer's disease. J. Alzheimer's Dis. 47 (2015), 231–242.
42. [42] El Haj, M., Antoine, P., Amouyel, P., Lambert, J.C., Pasquier, F., Kapogiannis, D., Apolipoprotein E (APOE) epsilon4 and episodic memory decline in Alzheimer's disease: a review. Ageing Res. Rev. 27 (2016), 15–22.
43. [43] Faber, E.S., Delaney, A.J., Sah, P., SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala. Nat. Neurosci. 8 (2005), 635–641.
44. [44] Finnema, S.J., Nabulsi, N.B., Eid, T., Detyniecki, K., Lin, S., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., Spencer, D.D., Mercier, J., Hannestad, J., Huang, Y., Carson, R.E., Imaging synaptic density in the living human brain. Sci. Transl. Med., 8, 2016, 348ra96.
45. [45] Frey, U., Morris, R.G.M., Synaptic tagging and long-term potentiation. Nature 385 (1997), 533–536.
46. [46] Gant, J.C., Blalock, E.M., Chen, K.C., Kadish, I., Porter, N.M., Norris, C.M., Thibault, O., Landfield, P.W., FK506-binding protein 1b/12.6: a key to aging-related hippocampal Ca2+ dysregulation?. Eur. J. Pharmacol. 739 (2014), 74–82.
47. [47] Gant, J.C., Chen, K.C., Kadish, I., Blalock, E.M., Thibault, O., Porter, N.M., Landfield, P.W., Reversal of aging-related neuronal Ca2+ dysregulation and cognitive impairment by delivery of a transgene encoding FK506-binding protein 12.6/1b to the hippocampus. J. Neurosci. 35 (2015), 10878–10887.
48. [48] Gomez-Sintes, R., Ledesma, M.D., Boya, P., Lysosomal cell death mechanisms in aging. Ageing Res. Rev., 2016, 10.1016/j.arr.2016.02.009.
49. 2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons. Channels Austin 5 (2011), 9–13.
50. 2+ influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice. J. Neurosci. 30 (2010), 12128–12137.
51. [51] Grigoryan, G., Segal, M., Ryanodine-mediated conversion of STP to LTP is lacking in synaptopodin-deficient mice. Brain Struct. Funct. 221 (2016), 2393–2397.
52. [52] Grimm, A., Friedland, K., Eckert, A., Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease. Biogerontology 17 (2016), 281–296.
53. [53] Habets, R.L., Borst, J.G., Post-tetanic potentiation in the rat calyx of Held synapse. J. Physiol. 564 (2005), 173–187.
54. [54] Hammond, R.S., Bond, C.T., Strassmaier, T., Ngo-Anh, T.J., Adelman, J.P., Maylie, J., Stackman, R.W., Small-conductance Ca2+-activated K+ channel type 2 (SK2) modulates hippocampal learning, memory, and synaptic plasticity. J. Neurosci. 26 (2006), 1844–1853.
55. [55] Hamos, J.E., DeGennaro, L.J., Drachman, D.A., Synaptic loss in Alzheimer's disease and other dementias. Neurology 39 (1989), 355–361.
56. [56] Harris, K.M., Weinberg, R.J., Ultrastructure of synapses in the mammalian brain. Cold Spring Harb. Perspect. Biol., 4, 2012, a005587.
57. [57] Hayashi, Y., Majewska, A.K., Dendritic spine geometry: functional implication and regulation. Neuron 46 (2005), 529–532.
58. [58] Hayrapetyan, V., Rybalchenko, V., Rybalchenko, N., Koulen, P., The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction. Cell Calcium 44 (2008), 507–518.
59. [59] Herrup, K., The case for rejecting the amyloid cascade hypothesis. Nat. Neurosci. 18 (2015), 794–799.
60. [60] Hidalgo, C., Arias-Cavieres, A., Calcium, reactive oxygen species, and synaptic plasticity. Physiol. Bethesda 31 (2016), 201–215.
61. [61] Higley, M.J., Sabatini, B.L., Calcium signaling in dendritic spines. Cold Spring Harb. Perspect. Biol., 4, 2012, a005686.
62. [62] Hinrich, A.J., Jodelka, F.M., Chang, J.L., Brutman, D., Bruno, A.M., Briggs, C.A., James, B.D., Stutzmann, G.E., Bennett, D.A., Miller, S.A., Rigo, F., Marr, R.A., Hastings, M.L., Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides. EMBO Mol. Med 8 (2016), 328–345.
63. [63] Hong, C., Seo, H., Kwak, M., Jeon, J., Jang, J., Jeong, E.M., Myeong, J., Hwang, Y.J., Ha, K., Kang, M.J., Lee, K.P., Yi, E.C., Kim, I.G., Jeon, J.H., Ryu, H., So, I., Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease. Brain 138 (2015), 3030–3047.
64. [64] Hou, P.F., Liu, Z.H., Li, N., Cheng, W.J., Guo, S.W., Knockdown of STIM1 improves neuronal survival after traumatic neuronal injury through regulating mGluR1-dependent Ca(2+) signaling in mouse cortical neurons. Cell Mol. Neurobiol. 35 (2015), 283–292.
65. [65] Hu, Y.B., Dammer, E.B., Ren, R.J., Wang, G., The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration. Transl. Neurodegener., 4, 2015, 18.
66. [66] Isaacs, A.M., Senn, D.B., Yuan, M., Shine, J.P., Yankner, B.A., Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium. J. Biol. Chem. 281 (2006), 27916–27923.
67. [67] Jacobsen, J.S., Wu, C.C., Redwine, J.M., Comery, T.A., Arias, R., Bowlby, M., Martone, R., Morrison, J.H., Pangalos, M.N., Reinhart, P.H., Bloom, F.E., Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103 (2006), 5161–5166.
68. [68] Jang, S.S., Chung, H.J., Emerging link between Alzheimer's disease and homeostatic synaptic plasticity. Neural Plast., 2016, 2016, 7969272.
69. [69] Kaja, S., Sumien, N., Shah, V.V., Puthawala, I., Maynard, A.N., Khullar, N., Payne, A.J., Forster, M.J., Koulen, P., Loss of spatial memory, learning, and motor function during normal aging Is accompanied by changes in brain presenilin 1 and 2 expression levels. Mol. Neurobiol. 52 (2015), 545–554.
70. [70] Kakizawa, S., Yamazawa, T., Iino, M., Nitric oxide-induced calcium release: activation of type 1 ryanodine receptor by endogenous nitric oxide. Channels Austin 7 (2013), 1–5.
71. [71] Kakizawa, S., Takeshima, H., Iino, M., Nitric oxide-induced calcium release: a novel calcium-mobilizing mechanism mediated by S-nitrosylation-dependent modulation of ryanodine receptor. Messenger 1 (2012), 133–140.
72. [72] Kilpatrick, B.S., Magalhaes, J., Beavan, M.S., McNeill, A., Gegg, M.E., Cleeter, M.W., Bloor-Young, D., Churchill, G.C., Duchen, M.R., Schapira, A.H., Patel, S., Endoplasmic reticulum and lysosomal Ca(2+) stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts. Cell Calcium 59 (2016), 12–20.
73. [73] Kobayashi, S., Yano, M., Suetomi, T., Ono, M., Tateishi, H., Mochizuki, M., Xu, X., Uchinoumi, H., Okuda, S., Yamamoto, T., Koseki, N., Kyushiki, H., Ikemoto, N., Matsuzaki, M., Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing inter-domain interactions within the ryanodine receptor. J. Am. Coll. Cardiol. 53 (2009), 1993–2005.
74. [74] Koffie, R.M., Meyer-Luehmann, M., Hashimoto, T., Adams, K.W., Mielke, M.L., Garcia-Alloza, M., Micheva, K.D., Smith, S.J., Kim, M.L., Lee, V.M., Hyman, B.T., Spires-Jones, T.L., Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl. Acad. Sci. USA 106 (2009), 4012–4017.
75. [75] Korogod, N., Lou, X., Schneggenburger, R., Presynaptic Ca2+ requirements and developmental regulation of posttetanic potentiation at the calyx of Held. J. Neurosci. 25 (2005), 5127–5137.
76. [76] Krols, M., van, I.G., Asselbergh, B., Kremer, A., Lippens, S., Timmerman, V., Janssens, S., Mitochondria-associated membranes as hubs for neurodegeneration. Acta Neuropathol. 131 (2016), 505–523.
77. [77] Kuchibhotla, K.V., Goldman, S.T., Lattarulo, C.R., Wu, H.Y., Hyman, B.T., Bacskai, B.J., Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59 (2008), 214–225.
78. [78] Lanner, J.T., Georgiou, D.K., Joshi, A.D., Hamilton, S.L., Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb. Perspect. Biol., 2, 2010, a003996.
79. [79] Lee, J.H., McBrayer, M.K., Wolfe, D.M., Haslett, L.J., Kumar, A., Sato, Y., Lie, P.P., Mohan, P., Coffey, E.E., Kompella, U., Mitchell, C.H., Lloyd-Evans, E., Nixon, R.A., Presenilin 1 maintains lysosomal Ca(2+) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep. 12 (2015), 1430–1444.
80. [80] Leissring, M.A., Akbari, Y., Fanger, C.M., Cahalan, M.D., Mattson, M.P., LaFerla, F.M., Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149 (2000), 793–798.
81. [81] Lessard, C.B., Lussier, M.P., Cayouette, S., Bourque, G., Boulay, G., The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells. Cell. Signal 17 (2005), 437–445.
82. [82] Leuba, G., Vernay, A., Vu, D., Walzer, C., Belloir, B., Kraftsik, R., Bouras, C., Savioz, A., Differential expression of LMO4 protein in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 30 (2004), 57–69.
83. [83] Li, Q., Rothkegel, M., Xiao, Z.C., Abraham, W.C., Korte, M., Sajikumar, S., Making synapses strong: metaplasticity prolongs associativity of long-term memory by switching synaptic tag mechanisms. Cereb. Cortex 24 (2014), 353–363.
84. [84] Liang, L., Wei, H., Dantrolene, a treatment for Alzheimer disease?. Alzheimer Dis. Assoc. Disord. 29 (2015), 1–5.
85. [85] Liang, Y., Yuan, L.L., Johnston, D., Gray, R., Calcium signaling at single mossy fiber presynaptic terminals in the rat hippocampus. J. Neurophysiol. 87 (2002), 1132–1137.
86. [86] Lima, B., Forrester, M.T., Hess, D.T., Stamler, J.S., S-Nitrosylation in cardiovascular signaling. Circ. Res. 106 (2010), 633–646.
87. [87] Liu, J., Supnet, C., Sun, S., Zhang, H., Good, L., Popugaeva, E., Bezprozvanny, I., The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease. Channels Austin 8 (2014), 230–242.
88. [88] Liu, X., Betzenhauser, M.J., Reiken, S., Meli, A.C., Xie, W., Chen, B.X., Arancio, O., Marks, A.R., Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. Cell 150 (2012), 1055–1067.
89. [89] Liu, X.A., Kadakkuzha, B., Pascal, B., Steckler, C., Akhmedov, K., Yan, L., Chalmers, M., Puthanveettil, S.V., New approach to capture and characterize synaptic proteome. Proc. Natl. Acad. Sci. USA 111 (2014), 16154–16159.
90. [90] Llano, I., Gonzalez, J., Caputo, C., Lai, F.A., Blayney, L.M., Tan, Y.P., Marty, A., Presynaptic calcium stores underlie large-amplitude miniature IPSCs and spontaneous calcium transients. Nat. Neurosci. 3 (2000), 1256–1265.
91. [91] Magi, S., Castaldo, P., Macri, M.L., Maiolino, M., Matteucci, A., Bastioli, G., Gratteri, S., Amoroso, S., Lariccia, V., Intracellular calcium dysregulation: implications for Alzheimer's disease. Biomed. Res. Int., 2016, 2016, 6701324.
92. [92] Marchetti, C., Marie, H., Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?. Rev. Neurosci. 22 (2011), 373–402.
93. [93] Martini-Stoica, H., Xu, Y., Ballabio, A., Zheng, H., The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 39 (2016), 221–234.
94. [94] Marx, S.O., Marks, A.R., Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases. J. Mol. Cell. Cardiol. 58 (2013), 225–231.
95. [95] Maxwell, J.T., Domeier, T.L., Blatter, L.A., Dantrolene prevents arrhythmogenic Ca2+ release in heart failure. Am. J. Physiol. Heart Circ. Physiol 302 (2012), H953–H963.
96. [96] Mayford, M., Siegelbaum, S.A., Kandel, E.R., Synapses and memory storage. Cold Spring Harb. Perspect. Biol., 4, 2012, a005751.
97. [97] Moccia, F., Zuccolo, E., Soda, T., Tanzi, F., Guerra, G., Mapelli, L., Lodola, F., D'Angelo, E., Stim and Orai proteins in neuronal Ca(2+) signaling and excitability. Front. Cell. Neurosci., 9, 2015, 153.
98. [98] Moncada, D., Ballarini, F., Viola, H., Behavioral tagging: a translation of the synaptic tagging and capture hypothesis. Neural Plast., 2015, 2015, 650780.
99. [99] Mufson, E.J., Ikonomovic, M.D., Counts, S.E., Perez, S.E., Malek-Ahmadi, M., Scheff, S.W., Ginsberg, S.D., Molecular and cellular pathophysiology of preclinical Alzheimer's disease. Behav. Brain Res. 311 (2016), 54–69.
100. 2+ signaling. Antioxid. Redox. Signal. 14 (2011), 1225–1235.
101. [101] Nakamura, T., Lipton, S.A., Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ. 18 (2011), 1478–1486.
102. [102] Neumann, H., Daly, M.J., Variant TREM2 as risk factor for Alzheimer's disease. N. Engl. J. Med. 368 (2013), 182–184.
103. [103] Neuner, S.M., Wilmott, L.A., Hoffmann, B.R., Mozhui, K., Kaczorowski, C.C., Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models. Behav. Brain Res., 2016, 10.1016/j.bbr.2016.06.002.
104. [104] Ngo-Anh, T.J., Bloodgood, B.L., Lin, M., Sabatini, B.L., Maylie, J., Adelman, J.P., SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines. Nat. Neurosci. 8 (2005), 642–649.
105. [105] O'Brien, F., Venturi, E., Sitsapesan, R., The ryanodine receptor provides high throughput Ca2+-release but is precisely regulated by networks of associated proteins: a focus on proteins relevant to phosphorylation. Biochem. Soc. Trans. 43 (2015), 426–433.
106. [106] Oda, T., Yang, Y., Uchinoumi, H., Thomas, D.D., Chen-Izu, Y., Kato, T., Yamamoto, T., Yano, M., Cornea, R.L., Bers, D.M., Oxidation of ryanodine receptor (RyR) and calmodulin enhance Ca(2+) release and pathologically alter, RyR structure and calmodulin affinity. J. Mol. Cell. Cardiol. 85 (2015), 240–248.
107. [107] Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y., LaFerla, F.M., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39 (2003), 409–421.
108. [108] Oh, M.M., Simkin, D., Disterhoft, J.F., Intrinsic hippocampal excitability changes of opposite signs and different origins in CA1 and CA3 pyramidal neurons underlie aging-related cognitive deficits. Front. Syst. Neurosci., 10, 2016, 10.3389/fnsys.2016.00052.
109. [109] Ong, H.L., de Souza, L.B., Ambudkar, I.S., Role of TRPC channels in store-operated calcium entry. Adv. Exp. Med. Biol. 898 (2016), 87–109.
110. [110] Onyango, I.G., Dennis, J., Khan, S.M., Mitochondrial dysfunction in Alzheimer's disease and the rationale for bioenergetics based therapies. Aging Dis. 7 (2016), 201–214.
111. [111] Oules, B., del Prete, D., Greco, B., Zhang, X., Lauritzen, I., Sevalle, J., Moreno, S., Paterlini-Brechot, P., Trebak, M., Checler, F., Benfenati, F., Chami, M., Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease. J. Neurosci. 32 (2012), 11820–11834.
112. [112] Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D.H., Mueller, S., Miller, T., Miller, C.C., There's something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases. Trends Neurosci. 39 (2016), 146–157.
113. [113] Pajak, B., Kania, E., Orzechowski, A., Killing me softly: connotations to unfolded protein response and oxidative stress in Alzheimer's disease. Oxid.Med. Cell Longev., 2016, 2016, 1805304.
114. [114] Paul-Pletzer, K., Yamamoto, T., Ikemoto, N., Jimenez, L., Morimoto, H., Williams, P., Ma, J., Parness, J., Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. Biochem. J. 387 (2005), 905–909.
115. [115] Payne, A.J., Kaja, S., Koulen, P., Regulation of ryanodine receptor-mediated calcium signaling by presenilins. Recept. Clin. Investig., 2, 2015, e449.
116. [116] Peng, J., Liang, G., Inan, S., Wu, Z., Joseph, D.J., Meng, Q., Peng, Y., Eckenhoff, M.F., Wei, H., Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. Neurosci. Lett. 516 (2012), 274–279.
117. 2+ homeostasis in rat nucleus accumbens neurons. Synapse 65 (2011), 168–180.
118. [118] Pierrot, N., Ghisdal, P., Caumont, A.S., Octave, J.N., Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J. Neurochem 88 (2004), 1140–1150.
119. [119] Platt, N., Speak, A.O., Colaco, A., Gray, J., Smith, D.A., Williams, I.M., Wallom, K.L., Platt, F.M., Immune dysfunction in Niemann-Pick disease type C. J. Neurochem 136 (2016), 74–80.
120. [120] Popugaeva, E., Bezprozvanny, I., Role of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer disease. Front. Mol. Neurosci., 6, 2013, 29.
121. [121] Popugaeva, E., Bezprozvanny, I., Can the calcium hypothesis explain synaptic loss in Alzheimer's disease?. Neurodegener. Dis. 13 (2014), 139–141.
122. [122] Popugaeva, E., Supnet, C., Bezprozvanny, I., Presenilins, deranged calcium homeostasis, synaptic loss and dysfunction in Alzheimer's disease. Messenger 1 (2012), 53–62.
123. [123] Prakriya, M., Lewis, R.S., Store-operated calcium channels. Physiol. Rev. 95 (2015), 1383–1436.
124. [124] Qin, Z., Zhou, X., Gomez-Smith, M., Pandey, N.R., Lee, K.F., Lagace, D.C., Beique, J.C., Chen, H.H., LIM domain only 4 (LMO4) regulates calcium-induced calcium release and synaptic plasticity in the hippocampus. J. Neurosci. 32 (2012), 4271–4283.
125. [125] Querfurth, H.W., Jiang, J., Geiger, J.D., Selkoe, D.J., Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells. J. Neurochem 69 (1997), 1580–1591.
126. [126] Redondo, R.L., Morris, R.G., Making memories last: the synaptic tagging and capture hypothesis. Nat. Rev. Neurosci. 12 (2011), 17–30.
127. [127] Ris, L., Capron, B., Sclavons, C., Liegeois, J.F., Seutin, V., Godaux, E., Metaplastic effect of apamin on LTP and paired-pulse facilitation. Learn. Mem. 14 (2007), 390–399.
128. [128] Robinson, J.L., Molina-Porcel, L., Corrada, M.M., Raible, K., Lee, E.B., Lee, V.M., Kawas, C.H., Trojanowski, J.Q., Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old. Brain 137 (2014), 2578–2587.
129. [129] Rossi, B., Maton, G., Collin, T., Calcium-permeable presynaptic AMPA receptors in cerebellar molecular layer interneurones. J. Physiol. 586 (2008), 5129–5145.
130. [130] Rowland, A.A., Voeltz, G.K., Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat. Rev. Mol. Cell Biol. 13 (2012), 607–625.
131. [131] Rybalchenko, V., Hwang, S.Y., Rybalchenko, N., Koulen, P., The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. Int.J.Biochem. Cell Biol. 40 (2008), 84–97.
132. [132] Sajikumar, S., Li, Q., Abraham, W.C., Xiao, Z.C., Priming of short-term potentiation and synaptic tagging/capture mechanisms by ryanodine receptor activation in rat hippocampal CA1. Learn. Mem. 16 (2009), 178–186.
133. [133] Santulli, G., Marks, A.R., Essential roles of intracellular calcium release channels in muscle, brain, metabolism, and aging. Curr. Mol. Pharmacol. 8 (2015), 206–222.
134. [134] Saura, C.A., Parra-Damas, A., Enriquez-Barreto, L., Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease. Front. Cell. Neurosci., 9, 2015, 318.
135. [135] Scimemi, A., Diamond, J.S., The number and organization of Ca2+ channels in the active zone shapes neurotransmitter release from Schaffer collateral synapses. J. Neurosci. 32 (2012), 18157–18176.
136. [136] Selkoe, D.J., Hardy, J., The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol. Med 8 (2016), 595–608.
137. [137] Sharp, A.H., Mcpherson, P.S., Dawson, T.M., Aoki, C., Campbell, K.P., Snyder, S.H., Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain. J. Neurosci. 13 (1993), 3051–3063.
138. 2+ leak channels. J. Biol. Chem. 287 (2012), 10933–10944.
139. [139] Shilling, D., Muller, M., Takano, H., Mak, D.O., Abel, T., Coulter, D.A., Foskett, J.K., Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis. J. Neurosci. 34 (2014), 6910–6923.
140. [140] Stevens, L.M., Brown, R.E., Reference and working memory deficits in the 3xTg-AD mouse between 2 and 15-months of age: a cross-sectional study. Behav. Brain Res. 278 (2015), 496–505.
141. [141] Stiller, I., Lizak, B., Banhegyi, G., Physiological functions of presenilins; beyond gamma-secretase. Curr. Pharm. Biotechnol. 15 (2014), 1019–1025.
142. [142] Stutzmann, G.E., The pathogenesis of Alzheimers disease: is it a lifelong “calciumopathy”?. Neuroscientist 13 (2007), 546–559.
143. 2+ handling in excitable cells in health and disease. Pharmacol. Rev. 63 (2011), 700–727.
144. 2+ disruptions in young, adult, and aged Alzheimer's Disease mice. J. Neurosci. 26 (2006), 5180–5189.
145. [145] Suliman, H.B., Piantadosi, C.A., Mitochondrial quality control as a therapeutic target. Pharmacol. Rev. 68 (2016), 20–48.
146. [146] Sun, S., Zhang, H., Liu, J., Popugaeva, E., Xu, N.J., Feske, S., White, C.L. III, Bezprozvanny, I., Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice. Neuron 82 (2014), 79–93.
147. [147] Supnet, C., Bezprozvanny, I., Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease. J. Alzheimer's Dis. 20:Suppl 2 (2010), S487–S498.
148. [148] Supnet, C., Bezprozvanny, I., Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. Cell Calcium 50 (2011), 303–309.
149. [149] Supnet, C., Grant, J., Kong, H., Westaway, D., Mayne, M., Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice. J. Biol. Chem. 281 (2006), 38440–38447.
150. [150] Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., Katzman, R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991), 572–580.
151. [151] Thibault, O., Gant, J.C., Landfield, P.W., Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6 (2007), 307–317.
152. [152] Thireau, J., Pasquie, J.L., Martel, E., Le Guennec, J.Y., Richard, S., New drugs vs. old concepts: a fresh look at antiarrhythmics. Pharmacol. Ther. 132 (2011), 125–145.
153. [153] Ullah, G., Demuro, A., Parker, I., Pearson, J.E., Analyzing and modeling the kinetics of amyloid beta pores associated with Alzheimer's disease pathology. PLoS One, 10, 2015, e0137357.
154. [154] Unni, V.K., Zakharenko, S.S., Zablow, L., DeCostanzo, A.J., Siegelbaum, S.A., Calcium release from presynaptic ryanodine-sensitive stores is required for long-term depression at hippocampal CA3-CA3 pyramidal neuron synapses. J. Neurosci. 24 (2004), 9612–9622.
155. [155] Van Petegem, F., Ryanodine receptors: allosteric ion channel giants. J. Mol. Biol. 427 (2015), 31–53.
156. [156] Verkhratsky, A., Parpura, V., Store-operated calcium entry in neuroglia. Neurosci. Bull. 30 (2014), 125–133.
157. [157] Walter, S., Atzmon, G., Demerath, E.W., Garcia, M.E., Kaplan, R.C., Kumari, M., Lunetta, K.L., Milaneschi, Y., Tanaka, T., Tranah, G.J., Völker, U., Yu, L., Arnold, A., Benjamin, E.J., Biffar, R., Buchman, A.S., Boerwinkle, E., Couper, D., De Jager, P.L., Evans, D.A., Harris, T.B., Hoffmann, W., Hofman, A., Karasik, D., Kiel, D.P., Kocher, T., Kuningas, M., Launer, L.J., Lohman, K.K., Lutsey, P.L., Mackenbach, J., Marciante, K., Psaty, B.M., Reiman, E.M., Rotter, J.I., Seshadri, S., Shardell, M.D., Smith, A.V., van Duijn, C., Walston, J., Zillikens, M.C., Bandinelli, S., Baumeister, S.E., Bennett, D.A., Ferrucci, L., Gudnason, V., Kivimaki, M., Liu, Y., Murabito, J.M., Newman, A.B., Tiemeier, H., Franceschini, N., A genome-wide association study of aging. Neurobiol. Aging, 32, 2011, 2109.
158. [158] Wang, J., Lu, R., Yang, J., Li, H., He, Z., Jing, N., Wang, X., Wang, Y., TRPC6 specifically interacts with APP to inhibit its cleavage by gamma-secretase and reduce Abeta production. Nat. Commun., 6, 2015, 8876.
159. [159] Wang, R., Zhong, X., Meng, X., Koop, A., Tian, X., Jones, P.P., Fruen, B.R., Wagenknecht, T., Liu, Z., Chen, S.R.W., Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor. J. Biol. Chem. 286 (2011), 12202–12212.
160. [160] Wang, Y., Wu, J., Rowan, M.J., Anwyl, R., Ryanodine produces a low frequency stimulation-induced NMDA receptor-independent long-term potentiation in the rat dentate gyrus in vitro. J. Physiol. 495 (1996), 755–767.
161. [161] Ward, A., Chaffman, M.O., Sorkin, E.M., Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs 32 (1986), 130–168.
162. [162] Waring, J.F., Anderson, D.J., Kroeger, P.E., Li, J., Chen, S.P., Hooker, B.A., Gopalakrishnan, M., Briggs, C.A., Gene expression changes related to synaptic deficits in the Tg2576 mouse model of Alzheimer's disease. J. Drug Metab. Toxicol, 3, 2012, 115.
163. [163] Wu, J., Ryskamp, D.A., Liang, X., Egorova, P., Zakharova, O., Hung, G., Bezprozvanny, I., Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington's disease mouse model. J. Neurosci. 36 (2016), 125–141.
164. [164] Yuste, J.E., Tarragon, E., Campuzano, C.M., Ros-Bernal, F., Implications of glial nitric oxide in neurodegenerative diseases. Front. Cell. Neurosci., 9, 2015, 322.
165. [165] Zhang, H., Wu, L., Pchitskaya, E., Zakharova, O., Saito, T., Saido, T., Bezprozvanny, I., Neuronal store-operated calcium entry and mushroom spine loss in amyloid precursor protein knock-in mouse model of Alzheimer's disease. J. Neurosci. 35 (2015), 13275–13286.
166. [166] Zhang, H., Liu, J., Sun, S., Pchitskaya, E., Popugaeva, E., Bezprozvanny, I., Calcium signaling, excitability and synaptic plasticity defects in mouse model of Alzheimer's disease. J. Alzheimer's Dis. 45 (2015), 561–580.
167. [167] Zhang, H., Sun, S., Herreman, A., De Strooper, B., Bezprozvanny, I., Role of presenilins in neuronal calcium homeostasis. J. Neurosci. 30 (2010), 8566–8580.
168. [168] Zhang, X., Garbett, K., Veeraraghavalu, K., Wilburn, B., Gilmore, R., Mirnics, K., Sisodia, S.S., A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J. Neurosci. 32 (2012), 8633–8648.
169. [169] Zhao, F., Li, P., Chen, S.R., Louis, C.F., Fruen, B.R., Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. J. Biol. Chem. 276 (2001), 13810–13816.
170. [170] Zhou, J., Du, W., Zhou, K., Tai, Y., Yao, H., Jia, Y., Ding, Y., Wang, Y., Critical role of TRPC6 channels in the formation of excitatory synapses. Nat. Neurosci. 11 (2008), 741–743.
171. [171] Zucker, R.S., Regehr, W.G., Short-term synaptic plasticity. Ann. Rev. Physiol. 64 (2002), 355–405.